EMEA-001676-PIP01-14-M03

Key facts

Invented name
Pifeltro
Active substance
Doravirine
Therapeutic area
Infectious diseases
Decision number
P/0254/2020
PIP number
EMEA-001676-PIP01-14-M03
Pharmaceutical form(s)
  • Tablet
  • Granules
Condition(s) / indication(s)
Treatment of human immunodeficiency virus type 1 (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.

Belgium
Tel. +33 180464738
Email: pip.information@merck.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating